Dr Reddys Laboratories Shares Up 11.8% Since SmarTrend's Buy Recommendation (RDY)

SmarTrend identified an Uptrend for Dr Reddys Laboratories (NYSE:RDY) on June 26th, 2015 at $55.12. In approximately 3 weeks, Dr Reddys Laboratories has returned 11.78% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.